Barry S. Taylor, PhD

Human Oncology & Pathogenesis Program

Taylor Lab

Researcher Barry Taylor focuses on defining the somatic abnormalities that mediate the genesis, progression, and response to therapy of human cancers.

Cameron W. Brennan, MD

Human Oncology & Pathogenesis Program

The Brennan Lab

Physician-scientist Cameron Brennan focuses on genomic analysis of human and mouse gliomas and medulloblastomas.

Charles L. Sawyers, MD

Human Oncology & Pathogenesis Program

The Sawyers Lab

Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.

Christine A. Iacobuzio-Donahue, MD, PhD

Human Oncology & Pathogenesis Program

The Christine Iacobuzio-Donahue Lab

Physician-scientist Christine Iacobuzio-Donahue studies the genomics and cell biology of pancreatic and other solid tumors as it relates to subclonal evolution, tumor progression, and metastasis.

David B. Solit, MD

Human Oncology & Pathogenesis Program

Pictured: Solit Lab

Physician-scientist David Solit studies human oncology and pathogenesis, genomics, oncogenes and tumor suppressors, cancer therapeutics, and clinical trials.

Emily H. Cheng, MD, PhD

Human Oncology & Pathogenesis Program

The Cheng Lab

Physician-scientist Emily Cheng focuses on the molecular mechanisms of cell death and their implications in tumorigenesis and cancer therapy, with primary emphasis on lung and kidney cancers.

Ingo K. Mellinghoff, MD

Human Oncology & Pathogenesis Program

The Mellinghoff Lab

Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.

James A. Fagin, MD

Human Oncology & Pathogenesis Program

The Fagin Lab

Physician-scientist James Fagin focuses on the pathogenesis of thyroid cancer and the role of oncogenic kinases.

Jorge S. Reis-Filho, MD, PhD

Human Oncology & Pathogenesis Program

Physician-scientist Jorge Reis-Filho focuses on the development of a predictive molecular classification for rare types of breast cancer and characterization of intratumor genetic heterogeneity in breast cancers.

José Baselga, MD, PhD

Human Oncology & Pathogenesis Program

Memorial Sloan Kettering Physician-in-Chief José Baselga studies mechanisms of resistance to targeted therapies and identification of novel therapeutic combinations in solid cancers.